U.S. Markets closed
  • S&P 500

    4,166.45
    -55.41 (-1.31%)
     
  • Dow 30

    33,290.08
    -533.37 (-1.58%)
     
  • Nasdaq

    14,030.38
    -130.97 (-0.92%)
     
  • Russell 2000

    2,237.75
    -49.71 (-2.17%)
     
  • Crude Oil

    71.50
    +0.46 (+0.65%)
     
  • Gold

    1,763.90
    -10.90 (-0.61%)
     
  • Silver

    25.84
    -0.01 (-0.04%)
     
  • EUR/USD

    1.1865
    -0.0045 (-0.3797%)
     
  • 10-Yr Bond

    1.4500
    -0.0610 (-4.04%)
     
  • Vix

    20.70
    +2.95 (+16.62%)
     
  • GBP/USD

    1.3809
    -0.0115 (-0.8272%)
     
  • USD/JPY

    110.1500
    -0.0810 (-0.0735%)
     
  • BTC-USD

    34,088.78
    -1,789.05 (-4.99%)
     
  • CMC Crypto 200

    888.52
    -51.42 (-5.47%)
     
  • FTSE 100

    7,017.47
    -135.96 (-1.90%)
     
  • Nikkei 225

    28,964.08
    -54.25 (-0.19%)
     

2021 Global Alzheimer's Disease Epidemiology and Patient Flow Report - ResearchAndMarkets.com

The "Global Alzheimer's Disease Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com's offering.

This research report, Global Alzheimer's Disease Epidemiology and Patient Flow Analysis - 2021, provides Alzheimer's Disease epidemiology, demographics, and patient flow. The data is presented by Pharma G7 countries including the US, France, Spain, Italy, UK, Japan.

The research provides population data to characterize Alzheimer's Disease patients, history of the disease at the population level (Alzheimer's Disease prevalence, Alzheimer's Disease incidence) and at the clinical level (from diagnosis to treated patients). It also helps to identify patient sub-groups (age, gender, sub-groups) to understand targeted population for research and development, commercialization.

Research scope:

  • Alzheimer's Disease patient flow: Alzheimer's Disease prevalence, diagnosed, and drug-treated patients

  • Countries: US, Germany, France, Italy, Spain, UK, Japan, G7 Countries

  • Demographics: Alzheimer's Disease patients by age group, gender

  • Forecast: Alzheimer's Disease epidemiology forecast to 2035

The data from this research will help executives:

  • Establish basis for Alzheimer's Disease market sizing, assessing market potential, and developing drug forecast models

  • Identify Alzheimer's Disease patients segments through age groups, gender, and disease sub-types

  • Develop Alzheimer's Disease population-based health management frameworks

  • Evaluate Alzheimer's Disease market opportunities, identify target patient population

  • Align marketing decisions with the Alzheimer's Disease target population

  • Communicate leadership and health authorities about your Alzheimer's Disease target patient population

Key Topics Covered:

  1. Research Methodology

  2. Alzheimer's Disease Patients Definition

  3. US Alzheimer's Disease Epidemiology and Patient Flow

  4. Germany Alzheimer's Disease Epidemiology and Patient Flow

  5. France Alzheimer's Disease Epidemiology and Patient Flow

  6. Italy Alzheimer's Disease Epidemiology and Patient Flow

  7. Spain Alzheimer's Disease Epidemiology and Patient Flow

  8. UK Alzheimer's Disease Epidemiology and Patient Flow

  9. Europe Alzheimer's Disease Epidemiology and Patient Flow

  10. Japan Alzheimer's Disease Epidemiology and Patient Flow

  11. Global Alzheimer's Disease Epidemiology and Patient Flow

  12. Sources

For more information about this report visit https://www.researchandmarkets.com/r/dcpmkb

View source version on businesswire.com: https://www.businesswire.com/news/home/20210513005494/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900